You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, look for clinical trials, and connect with others living with it — all in one place.
Open the full Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 hub →Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 is a rare condition. Also known as Fatal mitochondrial disease due to COXPD3. Tomeko brings together the specialists, research, clinical trials, treatments and community for Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:168566 · OMIM 610505 · ICD-10 E88.8 · GARD 0017035
Start by learning the basics from an authoritative source, find a specialist or center that sees Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, filtered to your area.
Tomeko shows live, recruiting studies for Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 from ClinicalTrials.gov on the hub.